Medgend Icon







discontinued


C-solve-2 FDA Approved Drugs

AKNE-MYCIN [ErythromycinC37H67NO13]
RX
-
2% (topical ointment)
Dow PharmJan 10, 1985
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ERY-TAB [ErythromycinC37H67NO13]
RX
-
250mg (oral tablet, delayed release)
333mg (oral tablet, delayed release)
500mg (oral tablet, delayed release)
Arbor Pharms LlcApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ERYC [ErythromycinC37H67NO13]
RX
-
250mg (oral capsule, delayed rel pellets)
Mayne PharmaApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ERYGEL [ErythromycinC37H67NO13]
RX
-
2% (topical gel)
Mylan Pharms IncOct 21, 1987
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ERYTHROMYCIN [ErythromycinC37H67NO13]
RX
-
0.5% (ophthalmic ointment)
2% (topical swab)
250mg (oral tablet)
500mg (oral tablet)
AkornJul 18, 1996
Bausch And LombJul 29, 1994
Perrigo Co TennesseeSep 26, 1983
Fougera PharmsSep 30, 1997
Perrigo New YorkJan 11, 1991
WockhardtOct 23, 1987
Arbor Pharms LlcApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

PCE [ErythromycinC37H67NO13]
RX
-
333mg (oral tablet, coated particles)
500mg (oral tablet, coated particles)
Arbor Pharms LlcSep 9, 1986
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.